Control Saliva Flow with

Sal-Tropine^TM Tablets

The Dry Alternative

SIMPLIFY YOUR WORK.

One dose of SAL-TROPINE (atropine sulfate, USP tablets) gives you control of patient saliva flow when you need it.

Why should your patients take a dose of SAL-TROPINE an hour before an appointment?

If patients have reduced saliva flow when they arrive at your office, you can achieve a dry field with less time and effort, and also

Increase patient comfort

Enhance visibility of tooth surfaces

Improve technical results with moisture-sensitive agents

Reduce the need to repeat procedures

Minimize interruptions during your procedure to remove pooled saliva

Maximize workload by minimizing procedural time

The Midwest Dental Evaluation Group concluded that "atropine truly does 'dry them out' and make your life a whole lot easier."(1) Dr. Gordon Christensen of Clinical Research Associates, wrote: "Atropine is, indeed, a useful medication for dentistry."(2)

SAL-TROPINE is labeled for dosing in adults, children, and infants (weighing down to 7 pounds). Doses should be adjusted according to weight. Dosing guidelines are provided in the prescribing information and may be exceeded in certain cases, as with large patients or heavy salivators.

Your office can order a supply of SAL-TROPINE by calling toll-free 1-800-755-9595. Bottles contain 100 tablets, have up to 3 year expiry dating, and are priced only $33.95. Call today and simplify your work.

For Procedures In Which A Dry Field Is Important
dentistry
SAL-TROPINE: 1 Hour Before.
(Administer On An Empty Stomach For Prompt Absorption)
Doses adjusted according to patient weight.
These doses may be exceeded in certain cases.

Please see Dentist Prescribing Information for complete warnings, precautions, and indications for use.

To Order Call Toll Free 1-800-755-9595

Orders Ouside the US: Please Fax Orders to
(480) 607-1971

References

1. Midwest Dental Evaluation Group. Atropine Sulfate Useful. Interface Vol.10, No. 56, Page 1. March/April 1998.

2. Christensen, G. Personal Correspondence. May 27, 1998.